Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
0.623
+0.013 (2.13%)
At close: Apr 28, 2026, 4:00 PM EDT
0.550
-0.073 (-11.72%)
Pre-market: Apr 29, 2026, 7:22 AM EDT

Basel Medical Group Cash Flow Statement

Millions SGD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22
Net Income
-10.642.071.781.98
Depreciation & Amortization
1.180.530.560.58
Asset Writedown & Restructuring Costs
10.56-0.05-
Provision & Write-off of Bad Debts
0.88-0.010.160.03
Other Operating Activities
-1.07-0.08-0.230.13
Change in Accounts Receivable
-8.69-0.420.540.01
Change in Inventory
-0.30.02-0.020
Change in Accounts Payable
4.030.39-0.220.06
Operating Cash Flow
-4.042.512.62.79
Operating Cash Flow Growth
--3.49%-6.89%-
Capital Expenditures
-10.9-0.01-0.01-0.09
Investing Cash Flow
-10.9-0.01-0.01-0.09
Short-Term Debt Issued
10.71.42--
Long-Term Debt Issued
4--1.03
Total Debt Issued
14.71.42-1.03
Short-Term Debt Repaid
-0.11-0--10.86
Long-Term Debt Repaid
-9.58-2.92-2.94-3.09
Total Debt Repaid
-9.69-2.92-2.94-13.95
Net Debt Issued (Repaid)
5-1.5-2.94-12.92
Issuance of Common Stock
9.75---
Other Financing Activities
1.74-0.270-
Financing Cash Flow
16.5-1.77-2.94-12.92
Foreign Exchange Rate Adjustments
-0.46---
Net Cash Flow
1.090.73-0.35-10.22
Free Cash Flow
-14.942.52.592.7
Free Cash Flow Growth
--3.56%-4.07%-
Free Cash Flow Margin
-131.58%24.89%26.61%25.37%
Free Cash Flow Per Share
-0.800.150.160.17
Cash Interest Paid
0.20.410.240.32
Cash Income Tax Paid
0.650.180.290.03
Levered Free Cash Flow
3.031.471.89-
Unlevered Free Cash Flow
3.161.582.04-
Change in Working Capital
-4.96-00.290.08
Source: S&P Capital IQ. Standard template. Financial Sources.